Cancer by Body Location

Seve Ballesteros 'reacts well' to brain tumour surgery

Seve Ballesteros, who underwent seven hours of surgery in Madrid on Tuesday to remove a brain tumour, was talking and reacting well when he was brought round the next morning. Surgery ordeal: Seve Ballesteros underwent...

Nearby tissue reveals liver cancer recurrence risk

By Gene Emery BOSTON (Reuters) - The key to whether liver cancer is curable may lie not with the tumor, but in the apparently healthy liver cells surrounding it, scientists said on Wednesday. An international research team...

Geoff Horsfield's Cancer Battle: Part 2

In the second part of givemefootball.com's exclusive interview with Geoff Horsfield, the striker talks about his future plans but first reveals the moment his worst fears were confirmed at Little Aston Hospital in Sutton...

Genentech Investors Closely Eye Avastin Study

has a strong third-quarter earnings report behind it, investors are turning their attention to a possible buyout by Swiss drugmaker Roche and a large clinical trial of cancer drug Avastin that could add billions of dollars in...

FDA Grants Orphan Drug Status to Reata's RTA 402 for Treatment of Pancreatic Cancer

Reata Pharmaceuticals, Inc. announces that RTA 402 has been granted orphan drug designation by the U.S. Food and Drug Administration (FDA) for the treatment of pancreatic cancer. About RTA 402 RTA 402 is an orally available,...

Synta Pharmaceuticals earns $25 million from GlaxoSmithKline for achieving Elesclomol milestones

Synta Pharmaceuticals Corp. yesterday announced that it has achieved operational milestones triggering $25 million in payment from GlaxoSmithKline (GSK) under its collaboration agreement for the development and...

Merck Serono?EURs Erbitux Nominated for International Prix Galien Award

•Prize recognizes outstanding innovation and excellence in pharmaceutical research DARMSTADT, Germany, Oct. 15 2008 – Merck Serono’s Erbitux® is one of the finalists for the prestigious International Prix Galien Award for...

Biothera Initiates Second Arm of Metastatic Colorectal Cancer Trial

Biothera announced today it began dosing patients in the second arm of its metastatic colorectal cancer (mCRC) trial in August. This arm of the trial is evaluating the combination therapy of its lead drug candidate, Imprime...

Genentech Q3 2008

October 14, 2008 | about stocks: Executives Kathee Littrell - Sue will speak to the recent results from our Phase III beta lung trail, in which Avastin did not provide incremental overall survival benefit with Tarceva in the...

Nicotine linked to breast cancer: study (AFP)

WASHINGTON (AFP) - Nicotine could play a role in the development and growth of tumors in breast cancer, according to a new study published Wednesday. Researchers studied for the first time the effects of nicotine on mammary...

1 2 3 4 5 next »